---
figid: PMC5341972__oncotarget-07-73188-g008
figtitle: MiR-128 reverses the gefitinib resistance of the lung cancer stem cells
  by inhibiting the c-met/PI3K/AKT pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC5341972
filename: oncotarget-07-73188-g008.jpg
figlink: /pmc/articles/PMC5341972/figure/F8/
number: F8
caption: Combination with miR-128 and gefitinib inhibits the PI3K/AKT pathway and
  induces the cell apoptosis by suppressing the expression of c-met in PC9-CSCs.
papertitle: MiR-128 reverses the gefitinib resistance of the lung cancer stem cells
  by inhibiting the c-met/PI3K/AKT pathway.
reftext: Jingjin Jiang, et al. Oncotarget. 2016 Nov 8;7(45):73188-73199.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.91522
figid_alias: PMC5341972__F8
figtype: Figure
redirect_from: /figures/PMC5341972__F8
ndex: adf489f9-df0b-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5341972__oncotarget-07-73188-g008.html
  '@type': Dataset
  description: Combination with miR-128 and gefitinib inhibits the PI3K/AKT pathway
    and induces the cell apoptosis by suppressing the expression of c-met in PC9-CSCs.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
---
